Skip to main content
. Author manuscript; available in PMC: 2024 Dec 2.
Published in final edited form as: Science. 2024 Oct 4;386(6717):eabq7248. doi: 10.1126/science.abq7248

Fig. 1. Gallery of human γδTCR structures solved in complex with their ligands highlighting diverse docking modes.

Fig. 1

(a) Vγ5Vδ1 TCR-CD1d-α-GalCer (b) Vγ3Vδ1 TCR-CD1d-sulfatide (c) Vγ2Vδ1 TCR-HLA-A2-MART1 (d) VγδVδ3 TCR-MR1-5-OP-RU (e) Vγ9Vδ1 TCR-MR1-5-OP-RU (f) Vγ4Vδ1 TCR-CD1a-endo (g) Vγ5Vδ1 TCR-T22. MHC and MHC-like molecules coloured in grey; distinct coloring for the γδTCRs.